Cancer

SEED Therapeutics Completes $30 Million Series A-3 Financing

KING OF PRUSSIA, Pa., Sept. 23, 2025 (GLOBE NEWSWIRE) -- SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rational…

3 months ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

MAINZ, Germany, September 23, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd.…

3 months ago

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

Registration Link Below for September 30, 2025 12 PM EST Presentation and Live Q&AKing of Prussia, Pennsylvania--(Newsfile Corp. - September…

3 months ago

AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86 Billion by 2035, Growing at a CAGR 21% | Vantage Market Research

Global AI in Oncology For Analytical Solutions Market to Transform Cancer Care Accelerating Early Detection, Precision Treatment, and Patient Outcomes.…

3 months ago

Genomenon and Compass Bioinformatics Partner to Transform Genomic Diagnostics in the U.S. and Japan

Mastermind® FLEX Data powers Compass Bioinformatics's InheriNext® platform, bringing unparalleled genomic evidence to leading institutes across US, Japan, and beyond…

3 months ago

Hemogenyx Pharmaceuticals PLC Signs Letter of Intent

Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in EstoniaFirst Potential Near-Term…

3 months ago

Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board

VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company")…

3 months ago

The Digital Medicine Society Unveils Healthcare 2030 — A Blueprint to Transform U.S. Healthcare in the Digital Era

Launch coincides with the Healthcare 2030 Summit in Washington, DC, bringing together top government officials, industry leaders, and patient advocates…

3 months ago

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

BOSTON, Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion…

3 months ago

Thynk Health Appoints Matt Rockhold as Chief Commercial Officer to Accelerate AI-Driven Cancer Detection Across U.S. Health Systems

LEXINGTON, Ky., Sept. 22, 2025 /PRNewswire/ -- Thynk Health, a leading innovator in AI-powered diagnostic platforms, today announced the appointment…

3 months ago